DexCom Earnings Preview: Revenue Growth of 6.7% Expected, Analysts Maintain Estimates
Medical device company DexCom (NASDAQ: DXCM) will release its earnings report tomorrow after market close. Analysts anticipate revenue growth of 6.7% year-over-year, reaching $1.10 billion. Adjusted earnings are projected at $0.50 per share.
Recent Performance and Analyst Expectations
In its previous quarter, DexCom met revenue estimates but reported earnings per share in line with expectations. Analysts covering the company have maintained their estimates over the past 30 days, indicating a stable outlook heading into earnings.
DexCom has consistently exceeded Wall Street's revenue expectations, missing only once in the last two years. It has surpassed estimates by an average of 1.4%.
Peer Performance and Market Sentiment
Healthcare equipment and supply companies ResMed and Intuitive Surgical have already reported their Q4 results. ResMed grew revenue by 10.3%, beating expectations by 1%, while Intuitive Surgical reported a 25.2% revenue increase, surpassing estimates by 6.5%.
Share prices in the healthcare equipment and supply segment have remained stable ahead of earnings. DexCom has experienced a 9.9% increase in its stock price in the past month, approaching earnings with an average analyst price target of $97.51.